Correction to: IL-17A Induces MIP-1α Expression in Primary Astrocytes Via Src/MAPK/PI3K/NF-kB Pathways: Implications for Multiple Sclerosis
J Neuroimmune Pharmacol
.
2021 Mar;16(1):207-208.
doi: 10.1007/s11481-020-09962-3.
Authors
Hongwei Yi
1
,
Ying Bai
1
,
Xinjian Zhu
1
,
Lin Lin
1
,
Lei Zhao
1
,
Xiaodong Wu
1
,
Shilpa Buch
2
,
Longxin Wang
3
,
Jie Chao
4
5
,
Honghong Yao
6
7
Affiliations
1
Department of Pharmacology, Medical School of Southeast University, Nanjing, China.
2
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
3
Department of Urology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
4
Department of Physiology, Medical School of Southeast University, Nanjing, China.
5
Department of Pharmacology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China.
6
Department of Pharmacology, Medical School of Southeast University, Nanjing, China. yaohh@seu.edu.cn.
7
Department of Pharmacology, Medical School of Southeast University, Nanjing, 210009, Jiangsu, China. yaohh@seu.edu.cn.
PMID:
33025380
DOI:
10.1007/s11481-020-09962-3
No abstract available
Publication types
Published Erratum